Literature DB >> 23356818

Ethnic differences in atrial fibrillation identified using implanted cardiac devices.

Chu-Pak Lau1, T David Gbadebo, Stuart J Connolly, Isabelle C Van Gelder, Alessandro Capucci, Michael R Gold, Carsten W Israel, Carlos A Morillo, Chung-Wah Siu, Haruhiko Abe, Mark Carlson, Hung-Fat Tse, Stefan H Hohnloser, Jeff S Healey.   

Abstract

INTRODUCTION: Atrial fibrillation (AF) is suggested to be less common among black and Asian individuals, which could reflect bias in symptom reporting and access to care. In the Asymptomatic AF and Stroke Evaluation in Pacemaker Patients and the AF Reduction Atrial Pacing Trial (ASSERT), patients with hypertension but no history of AF had AF recorded via an implanted pacemaker or defibrillator, thus allowing both symptomatic and asymptomatic AF incidence to be determined without ascertainment bias. METHODS AND
RESULTS: The ASSERT enrolled 2,580 patients in 23 countries in North America, Europe, and Asia. AF was defined as device-recorded AF episodes >190/min, lasting either for >6 minutes or >6 hours in duration. All ethnic groups with >50 patients were enrolled. Ethnic groups studied include Europeans (n = 1900), black Africans (n = 73), Chinese (n = 89), and Japanese (n = 105) patients. Compared to Europeans, black Africans had more risk factors for AF such as heart failure (27.8 vs 14.6%) and diabetes (41.7 vs 26.3%). At 2.5 years follow-up, all 3 non-European races had a lower incidence of AF (8.3%, 10.1%, and 9.5% vs 18.0%, respectively, for AF>6 minutes, P < 0.006). When adjusted for baseline difference, Chinese had a lower incidence of AF > 6 minutes (P < 0.007), and Japanese and black Africans had a lower incidence of AF > 6 hours (P < 0.04 and P = 0.057, respectively).
CONCLUSIONS: Black Africans, Chinese, and Japanese had lower incidence of AF compared to Europeans. In the case of black Africans, this is despite an increased prevalence of AF risk factors.
© 2013 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2013        PMID: 23356818     DOI: 10.1111/jce.12066

Source DB:  PubMed          Journal:  J Cardiovasc Electrophysiol        ISSN: 1045-3873


  25 in total

1.  Effect of race on outcomes (stroke and death) in patients >65 years with atrial fibrillation.

Authors:  Rajesh Kabra; Peter Cram; Saket Girotra; Mary Vaughan Sarrazin
Journal:  Am J Cardiol       Date:  2015-04-16       Impact factor: 2.778

2.  Efficacy and safety of dabigatran, rivaroxaban, and warfarin for stroke prevention in Chinese patients with atrial fibrillation: the Hong Kong Atrial Fibrillation Project.

Authors:  Wen-Hua Li; Duo Huang; Chern-En Chiang; Chu-Pak Lau; Hung-Fat Tse; Esther W Chan; Ian C K Wong; Gregory Y H Lip; Pak-Hei Chan; Chung-Wah Siu
Journal:  Clin Cardiol       Date:  2016-11-28       Impact factor: 2.882

3.  Electrocardiographic Left Atrial Abnormality and Risk of Stroke: Northern Manhattan Study.

Authors:  Hooman Kamel; Madeleine Hunter; Yeseon P Moon; Shadi Yaghi; Ken Cheung; Marco R Di Tullio; Peter M Okin; Ralph L Sacco; Elsayed Z Soliman; Mitchell S V Elkind
Journal:  Stroke       Date:  2015-09-22       Impact factor: 7.914

Review 4.  Oral anticoagulants for Asian patients with atrial fibrillation.

Authors:  Ian Sabir; Kaivan Khavandi; Jack Brownrigg; A John Camm
Journal:  Nat Rev Cardiol       Date:  2014-03-11       Impact factor: 32.419

Review 5.  Global epidemiology of atrial fibrillation.

Authors:  Faisal Rahman; Gene F Kwan; Emelia J Benjamin
Journal:  Nat Rev Cardiol       Date:  2014-08-12       Impact factor: 32.419

6.  Novel genetic markers associate with atrial fibrillation risk in Europeans and Japanese.

Authors:  Steven A Lubitz; Kathryn L Lunetta; Honghuang Lin; Dan E Arking; Stella Trompet; Guo Li; Bouwe P Krijthe; Daniel I Chasman; John Barnard; Marcus E Kleber; Marcus Dörr; Kouichi Ozaki; Albert V Smith; Martina Müller-Nurasyid; Stefan Walter; Joanne M Murabito; Moritz F Sinner; Vilmundur Gudnason; Stephan B Felix; Winfried März; Mina Chung; Christine M Albert; Bruno H Stricker; Toshihiro Tanaka; Susan R Heckbert; J Wouter Jukema; Alvaro Alonso; Emelia J Benjamin; Patrick T Ellinor; Sunil K Agarwal; Joshua C Bis; Jennifer A Brody; Lin Y Chen; Brendan M Everett; Ian Ford; Oscar H Franco; Tamara B Harris; Albert Hofman; Stefan Kääb; Saagar Mahida; Sekar Kathiresan; Michiaki Kubo; Lenore J Launer; Peter W MacFarlane; Jared W Magnani; Barbara McKnight; David D McManus; Annette Peters; Bruce M Psaty; Lynda M Rose; Jerome I Rotter; Guenther Silbernagel; Jonathan D Smith; Nona Sotoodehnia; David J Stott; Kent D Taylor; Andreas Tomaschitz; Tatsuhiko Tsunoda; Andre G Uitterlinden; David R Van Wagoner; Uwe Völker; Henry Völzke
Journal:  J Am Coll Cardiol       Date:  2014-01-30       Impact factor: 24.094

7.  Racial Differences in the Prevalence and Outcomes of Atrial Fibrillation in Patients Hospitalized With Heart Failure.

Authors:  Subir Bhatia; Mohammad Qazi; Ashwini Erande; Kunjan Shah; Alpesh Amin; Pranav Patel; Shaista Malik
Journal:  Am J Cardiol       Date:  2016-02-17       Impact factor: 2.778

8.  Atrial Fibrillation and Race - A Contemporary Review.

Authors:  Michael K D Amponsah; Emelia J Benjamin; Jared W Magnani
Journal:  Curr Cardiovasc Risk Rep       Date:  2013-10

9.  Differences by Race/Ethnicity in the Prevalence of Clinically Detected and Monitor-Detected Atrial Fibrillation: MESA.

Authors:  Susan R Heckbert; Thomas R Austin; Paul N Jensen; Lin Y Chen; Wendy S Post; James S Floyd; Elsayed Z Soliman; Richard A Kronmal; Bruce M Psaty
Journal:  Circ Arrhythm Electrophysiol       Date:  2020-01-14

10.  The prevalence of atrial fibrillation on 48-hour ambulatory electrocardiography in African Americans compared to Whites: The Atherosclerosis Risk in Communities (ARIC) study.

Authors:  Laura R Loehr; Elsayed Z Soliman; Anna K Poon; David Couper; Lin Yee Chen; Thomas H Mosley; Lynne E Wagenknecht; Eric A Whitsel; Alvaro Alonso; Lisa Wruck; Gerardo Heiss
Journal:  Am Heart J       Date:  2019-07-03       Impact factor: 4.749

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.